Skip to main content

$0.525 (0.00%)

High

$0.53

Low

$0.53

Trades

7

Turnover

$2,970

Volume

5,657
30 June 2023 at 12:06pm
Register to track GSS and receive email alerts.

CE-IVD received for STI test

StockBot

416,823 posts

GSS released this announcement to the ASX on 27 January 2021, 11:38. The announcement is marked as price sensitive, and is 1 page(s) in length and 136.48kb in size.

You can view all announcements from GSS and see how they appear on a price chart on the announcements page.

At the date of this announcement, GSS was 0.004% short sold according to ASIC data. It was ranked the 562nd most shorted stock on the ASX. It remains ranked 640th as of the latest reported data (03 February 2025).

Other Recent Announcements from GSS
CFO/Company Secretary Appointment 16 June 2023, 8:54
Quarterly update and Appendix 4C 28 April 2023, 8:59
Company Secretary/CFO Appointment/Resignation 21 March 2023, 9:12
CE-IVD received for STI test 27 January 2021, 11:38
Quarterly update and Appendix 4C 21 January 2021, 11:28
Supply agreement with major US customer 23 December 2020, 12:18
Presenting at Bell potter healthcare conference 26 November 2020, 9:56
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track GSS and receive email alerts.